Stool testing for Helicobacter pylori infection: yet another noninvasive alternative

Area of Science:

• Gastroenterology
• Infectious Diseases
• Diagnostic Microbiology

Background:

• Helicobacter pylori (H. pylori) infection diagnosis relies on invasive and non-invasive methods.
• Accurate and accessible diagnostic tools are crucial for effective H. pylori management.
• Current non-invasive tests, like the carbon-13 urea breath test, have limitations.

Purpose of the Study:

• To evaluate the diagnostic accuracy of the HpSA ELISA antigen stool test for active H. pylori infection.
• To compare the stool test's performance against a gold standard and the carbon-13 urea breath test.
• To assess the stool test's reliability in both treatment-naïve and post-treatment patient populations.

Main Methods:

• A prospective, multicenter study involving 11 European centers.
• Compared HpSA stool antigen assay results with a gold standard (biopsies, culture, rapid urease testing).
• Compared stool test accuracy with the carbon-13 urea breath test in 501 treatment-naïve patients and 107 post-treatment patients.

Main Results:

• Pre-treatment: HpSA stool test sensitivity 94.1%, specificity 91.8%.
• Pre-treatment: Carbon-13 urea breath test sensitivity 95.3%, specificity 97.7%.
• Post-treatment: HpSA stool test sensitivity 90%, specificity 95.3%.
• Post-treatment: Carbon-13 urea breath test sensitivity 90%, specificity 98.9%.

Conclusions:

• HpSA stool testing is a reliable and user-friendly method for diagnosing H. pylori infection.
• The stool test demonstrates comparable accuracy to the carbon-13 urea breath test.
• Advantages include simpler sample collection, no need for trained personnel, and no requirement for expensive equipment.